ANTARES PHARMA INC - COM (ATRS)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
72,978,549
Share change
+4,178,887
Total reported value
$291,204,980
Put/Call ratio
846%
Price per share
$3.99
Number of holders
174
Value change
+$22,239,126
Number of buys
67
Number of sells
64

Institutional Holders of ANTARES PHARMA INC - COM (ATRS) as of Q4 2020

As of 31 Dec 2020, ANTARES PHARMA INC - COM (ATRS) was held by 174 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 72,978,549 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, Rubric Capital Management LP, Sargent Investment Group, LLC, Centric Wealth Management, GEODE CAPITAL MANAGEMENT, LLC, SILVERCREST ASSET MANAGEMENT GROUP LLC, and ORACLE INVESTMENT MANAGEMENT INC. This page lists 174 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.